Fidelity Investments
RPTX

Fidelity Investments’s Repare Therapeutics RPTX Stock Holding History

Fidelity Investments’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,600
Closed -$1.58K – 5477
2025
Q1 		$1.58K Buy
+1,600
New +$1.93K ﹤0.01% 4916
2023
Q4 		– Sell
-1,079,847
Closed -$13M – 5618
2023
Q3 		$13M Sell
1,079,847
-88,560
-8% -$914K ﹤0.01% 1742
2023
Q2 		$12.4M Buy
1,168,407
+247,464
+27% +$2.55M ﹤0.01% 1794
2023
Q1 		$9.06M Buy
920,943
+44,765
+5% +$514K ﹤0.01% 1913
2022
Q4 		$12.9M Buy
876,178
+698,948
+394% +$10.5M ﹤0.01% 1798
2022
Q3 		$2.15M Sell
177,230
-1,198,158
-87% -$15.4M ﹤0.01% 2412
2022
Q2 		$19.2M Sell
1,375,388
-1,564,435
-53% -$18.4M ﹤0.01% 1664
2022
Q1 		$41.9M Sell
2,939,823
-81,490
-3% -$1.21M ﹤0.01% 1473
2021
Q4 		$63.7M Buy
3,021,313
+237,537
+9% +$5.6M ﹤0.01% 1321
2021
Q3 		$73M Buy
2,783,776
+8,723
+0.3% +$282K 0.01% 1251
2021
Q2 		$86.5M Buy
2,775,053
+7,220
+0.3% +$236K 0.01% 1181
2021
Q1 		$84.9M Buy
2,767,833
+10,458
+0.4% +$355K 0.01% 1138
2020
Q4 		$94.6M Buy
2,757,375
+866
+0% +$25.9K 0.01% 1054
2020
Q3 		$84.8M Buy
2,756,509
+229,056
+9% +$6.07M 0.01% 991
2020
Q2 		$78.4M Buy
+2,527,453
New +$81.1M 0.01% 980

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments's RPTX Position: Q2 2025 in Review

Fidelity Investments sold out of Repare Therapeutics (RPTX) in Q2 2025, closing a stake of 1,600 shares — an estimated $1.58K sold.

Fidelity Investments first reported a position in RPTX in Q2 2020 and held it in 15 quarters. The position peaked at $94.6M in Q4 2020. 50 funds tracked by Wall St. Rank hold RPTX as of Q2 2025.

  • Fidelity Investments reported no remaining Repare Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Fidelity Investments sold 1,600 Repare Therapeutics shares in Q2 2025, an estimated $1.58K.
  • Fidelity Investments first reported a position in Repare Therapeutics in Q2 2020 and held it in 15 quarters.
  • Fidelity Investments's Repare Therapeutics position peaked at $94.6M in Q4 2020.
  • 50 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.